Dr Ralph William Tack, MD, MPH | |
715 S Taft Ave, Fremont, OH 43420-3200 | |
(419) 333-2738 | |
(419) 333-6416 |
Full Name | Dr Ralph William Tack |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
Location | 715 S Taft Ave, Fremont, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578620621 | NPI | - | NPPES |
35048041 | Other | OH | MEDICAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 35048041 (Ohio) | Primary |
207Q00000X | Family Medicine | 35048041 (Ohio) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Ralph William Tack, MD, MPH 715 S Taft Ave, Fremont, OH 43420-3200 Ph: (419) 333-2738 | Dr Ralph William Tack, MD, MPH 715 S Taft Ave, Fremont, OH 43420-3200 Ph: (419) 333-2738 |
News Archive
What drives a person to smoke cigarettes - and keeps one out of six U.S. adults addicted to tobacco use, at a cost of 480,000 premature deaths each year despite decades of anti-smoking campaigns?
For years doctors have used the body mass index (BMI), a ratio of height and weight, to characterize the clinical weight status of their patients.
For the visually impaired, using a mobile device hasn't always been easy. Kyocera Kona from Sprint (NYSE: S) helps to solve that problem by providing an easy-to-use compact flip phone that is the first feature phone in the industry to offer verbal translation enabling Internet browsing.
Dayan B. Goodenowe and colleagues report in the November 2007 issue of the Journal of Lipid Research that people with Alzheimer's disease and related conditions exhibit decreased blood levels of an important brain chemical called ethanolamine plasmalogen, even at the very early stages of the disease.
Analysis from business intelligence provider GBI Research - Breast Cancer Therapeutics in Major Developed Markets to 2020 - forecasts the breast cancer treatment market to increase in value from $9.2 billion in 2013 to more than $13.1 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.1%.
› Verified 9 days ago